On Invalid Date, Immunome (NASDAQ: IMNM) reported Q4 2023 earnings per share (EPS) of -$4.22, up 559.38% year over year. Total Immunome earnings for the quarter were -$92.63 million. In the same quarter last year, Immunome's earnings per share (EPS) was -$0.64.
As of Q2 2024, Immunome's earnings has grown year over year. Immunome's earnings in the past year totalled -$106.81 million.
What is IMNM's earnings date?
Immunome's earnings date is Invalid Date. Add IMNM to your watchlist to be reminded of IMNM's next earnings announcement.
What was IMNM's revenue last quarter?
On Invalid Date, Immunome (NASDAQ: IMNM) reported Q4 2023 revenue of $3.83 million up Infinity% year over year. In the same quarter last year, Immunome's revenue was $0.00.
What was IMNM's revenue growth in the past year?
As of Q2 2024, Immunome's revenue has grown null year over year. Immunome's revenue in the past year totalled $14.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.